Total Payments
$696.46
2024 Payments
$70.66
Companies
16
Transactions
36
Medicare Patients
3,188
Medicare Billing
$233,057
Payment Breakdown by Category
Food & Beverage$672.20 (96.5%)
Education$24.26 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $672.20 | 35 | 96.5% |
| Education | $24.26 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Oyster Point Pharma, Inc. | $120.76 | 5 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $75.96 | 4 | $0 (2021) |
| Horizon Therapeutics plc | $70.73 | 3 | $0 (2023) |
| Alcon Vision LLC | $67.60 | 4 | $0 (2024) |
| Shire North American Group Inc | $57.61 | 3 | $0 (2017) |
| Allergan, Inc. | $46.93 | 3 | $0 (2021) |
| CooperVision Inc. | $44.30 | 3 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $43.95 | 2 | $0 (2023) |
| BIOTISSUE HOLDINGS, INC. | $32.70 | 2 | $0 (2023) |
| ABBVIE INC. | $24.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70.66 | 3 | Oyster Point Pharma, Inc. ($24.33) |
| 2023 | $153.82 | 7 | Oyster Point Pharma, Inc. ($69.85) |
| 2022 | $79.21 | 4 | Oyster Point Pharma, Inc. ($26.58) |
| 2021 | $199.54 | 12 | Alcon Vision LLC ($45.57) |
| 2019 | $63.19 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($41.61) |
| 2017 | $130.04 | 7 | Shire North American Group Inc ($57.61) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Ophthalmology | ||||||
| 03/14/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: EYE CARE | ||||||
| 02/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Dry eyes | ||||||
| 10/19/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: DRY EYE | ||||||
| 08/11/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: TEPEZZA | ||||||
| 07/17/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Ophthalmology | ||||||
| 05/25/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: DRY EYE | ||||||
| 04/17/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 03/16/2023 | CooperVision Inc. | MiSight Contact Lens (Device) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Devices | ||||||
| 02/09/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: DRY EYE | ||||||
| 12/01/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: DRY EYE | ||||||
| 10/20/2022 | CooperVision Inc. | Biofinity Contact Lens (Device) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Devices | ||||||
| 10/19/2022 | BioTissue Holdings, Inc. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 01/18/2022 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Ophthalmology | ||||||
| 12/17/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: DRY EYE | ||||||
| 12/02/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: TEPEZZA | ||||||
| 11/10/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Musculoskeletal | ||||||
| 11/08/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Education | In-kind items and services | $24.26 | General |
| Category: TEPEZZA | ||||||
| 10/05/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: DRY EYE | ||||||
| 09/22/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Ophthalmology | ||||||
| 08/26/2021 | Alcon Vision LLC | MARLO (Device) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Ophthalmology | ||||||
| 07/29/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Ophthalmology | ||||||
| 06/21/2021 | Alcon Vision LLC | AcrySof IQ VIVITY IOL (Device) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Ophthalmology | ||||||
| 05/27/2021 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Devices | ||||||
| 04/08/2021 | Alcon Vision LLC | MARLO (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 763 | 897 | $142,880 | $53,995 |
| 2022 | 7 | 773 | 904 | $141,670 | $57,575 |
| 2021 | 8 | 852 | 1,049 | $153,779 | $69,196 |
| 2020 | 9 | 800 | 938 | $127,900 | $52,291 |
Total Patients
3,188
Total Services
3,788
Medicare Billing
$233,057
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 362 | 440 | $88,880 | $33,690 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 142 | $20,590 | $8,464 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $10,335 | $3,484 | 33.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 69 | 73 | $7,300 | $3,235 | 44.3% |
| 92134 | Imaging of retina | Office | 2023 | 71 | 87 | $6,525 | $2,371 | 36.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 86 | 94 | $7,050 | $2,266 | 32.1% |
| 92250 | Photography of the retina | Office | 2023 | 22 | 22 | $2,200 | $484.77 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 360 | 422 | $81,500 | $34,104 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 141 | $19,435 | $8,080 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 70 | 70 | $18,110 | $7,033 | 38.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 64 | 71 | $7,100 | $3,123 | 44.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 92 | 99 | $7,425 | $2,387 | 32.1% |
| 92134 | Imaging of retina | Office | 2022 | 65 | 80 | $6,000 | $2,271 | 37.8% |
| 92250 | Photography of the retina | Office | 2022 | 18 | 21 | $2,100 | $576.77 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 386 | 499 | $89,110 | $42,044 | 47.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 76 | 76 | $19,532 | $8,516 | 43.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 142 | $17,532 | $7,797 | 44.5% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 78 | 86 | $8,600 | $3,850 | 44.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 101 | 118 | $8,850 | $3,199 | 36.1% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 70 | 89 | $6,675 | $2,469 | 37.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 18 | 23 | $1,880 | $862.73 | 45.9% |
| 92250 | Photography of the retina | Office | 2021 | 16 | 16 | $1,600 | $459.75 | 28.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 366 | 442 | $73,270 | $30,798 | 42.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 108 | 140 | $16,056 | $6,875 | 42.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 54 | 54 | $13,744 | $5,647 | 41.1% |
About Dr. Joshua Baker, O.D
Dr. Joshua Baker, O.D is a Optometrist healthcare provider based in Dallas, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679577027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Baker, O.D has received a total of $696.46 in payments from pharmaceutical and medical device companies, with $70.66 received in 2024. These payments were reported across 36 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($672.20).
As a Medicare-enrolled provider, Baker has provided services to 3,188 Medicare beneficiaries, totaling 3,788 services with total Medicare billing of $233,057. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Dallas, NC
- Active Since 06/13/2005
- Last Updated 03/12/2008
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1679577027
Products in Payments
- TYRVAYA (Drug) $120.76
- TEPEZZA (Drug) $70.73
- XIIDRA (Drug) $57.61
- INFUSE (Device) $43.95
- VYZULTA (Drug) $34.35
- RESTASIS MULTIDOSE (Drug) $34.02
- MARLO (Device) $33.36
- PROKERA (Device) $32.70
- BIOTRUE ONE DAY (Device) $24.67
- LUMIGAN (Drug) $24.30
- DAILIES (Device) $23.44
- CEQUA (Drug) $21.58
- Tecnis 1-piece IOL (Device) $18.24
- ZYLET (Drug) $17.84
- Omidria (Drug) $17.35
- BESIVANCE (Drug) $16.94
- MiSight Contact Lens (Device) $15.34
- Biofinity Contact Lens (Device) $14.72
- MyDay Contact Lens (Device) $14.24
- Xeomin (Biological) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Dallas
Dr. Laurence Thomas, O.d, O.D
Optometrist — Payments: $163,565
Optometrist $163,565
Kenneth Uzick, O.d, O.D
Optometrist — Payments: $61,059
Optometrist $61,059
Amanda Hoelscher, Od, OD
Optometrist — Payments: $16,203
Optometrist $16,203
Dr. Linda Hatton, O.d, O.D
Optometrist — Payments: $14,670
Optometrist $14,670
Dr. Slayton Ebeling, O.d, O.D
Optometrist — Payments: $13,635
Optometrist $13,635
Michael Burton, Od, OD
Optometrist — Payments: $12,447
Optometrist $12,447